PharMolix Inc. is an AI & Biotechnology company that aims to revolutionize the biomedical industry with multi-modal AI foundation models and intelligent agents. The company comprises top scientists and leaders from both AI and biomedical domains.
PharMolix has developed the world's first 100B multi-modal biomedical AI foundation model, and the next generation conversational drug discovery assistant, ChatDD (Chat for Drug Discovery & Development). ChatDD combines human expert knowledge with insights from multi-modal AI foundation models, enabling a new paradigm of drug R&D. The product is used in pharmaceutical business Intelligence, drug discovery, clinical trials, among others.
PharMolix is named the recipient of the 2024 BEYOND Healthcare Innovation Award, and among the 2024 Top 30 AI Innovative companies (by InvestorsCN) and the 2023 Top 10 ScienceAI companies in China. PharMolix is backed by top VC firms in the industry.
Company Details
- Employees
- 7
- Founded
- -
- Industry
- Technology, Information And Internet
Pharmolix Inc. Questions
Pharmolix Inc.'s LinkedIn profile is https://www.linkedin.com/company/pharmolix
Pharmolix Inc. has
7 employees.
View email and phone details for 7
employees at Pharmolix Inc..
Pharmolix Inc.'s industry is
Technology, Information and Internet
Pharmolix Inc.'s top competitors are
Xtalpi Inc.,
Hewlett Packard Enterprise,
Dow,
Chemical.ai,
Bayland Capital 康君资本,
真知创投 Verity Ventures,
Wuxi Apptec,
清华大学智能产业研究院,
Ub-Center For Drug Discovery,
Wei Retreat.
Pharmolix Inc.'s categories are Technology, Information and Internet
Pharmolix Inc.'s founding year is 2023
